Lv11
70 积分 2024-12-06 加入
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
9小时前
待确认
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
1个月前
已完结
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
1个月前
已完结
Radiotherapy-Triggered Proteolysis Targeting Chimera Prodrug Activation in Tumors
1个月前
已完结
Discovery of a potent BRD4 PROTAC and evaluation of its bioactivity in breast cancer cell lines
1个月前
已完结
GLUTs-Facilitated Targeting BRD4 Degradation in Breast Cancer through Carbohydrate-Conjugated PROTACs
1个月前
已完结
Targeting Myc through BET-PROTAC elicits potent anti-lymphoma activity in diffuse large B cell lymphoma
1个月前
已完结
Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity
1个月前
已完结
Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity
1个月前
已完结
Acquired resistance to MRG003 in nasopharyngeal carcinoma PDX models: underlying mechanisms and combination strategies to overcome resistance
1个月前
已关闭
皖公网安备34019202002308
